MedTrace Logo

Bipolar Hemostatic Forceps Versus Standard Therapy in Acute Non-variceal Upper GI Bleeding

NCT05353062 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-01-27

No results posted yet for this study

Summary

Bipolar hemostatic forceps will be tested against standard therapy in active, non-variceal, upper gastrointestinal bleeding by a prospective, randomized trial

Conditions

  • Gastrointestinal Hemorrhage

Interventions

PROCEDURE

Hemostatic therapy

Bipolar hemostatic forceps

PROCEDURE

Endoscopic therapy with hemoclip +/- injection of epinephrine solution

Endoscopic therapy with hemoclip +/- injection of epinephrine solution

Sponsors & Collaborators

  • PENTAX Europe GmbH

    collaborator INDUSTRY

  • Theresienkrankenhaus und St. Hedwig-Klinik GmbH

    lead OTHER

Principal Investigators

  • Daniel Schmitz, MD · Helios Kliniken Schwerin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-01-01
Completion
2024-02-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05353062 on ClinicalTrials.gov